Deliver Your News to the World

Oriola-KD to distribute Schering-Plough’s Pharmaceuticals in Finland


28 December 2006 - Oriola-KD Corporation and Schering-Plough have agreed on the distribution of Schering-Plough’s human pharmaceuticals in Finland starting from 1 January 2007.

The wholesale value of Schering-Plough pharmaceuticals is 32 million euros in 2006. The company’s share on Finnish pharmaceutical wholesale value in January-October was 1.7 per cent (source: IMS Health).

“The target of Schering-Plough is to earn its clients’ and stakeholders’ trust every day. This sets the bar high for our strategic partners working with our products”, says Schering-Plough’s General Manager, Mr Jouko Timosaari.

“We welcome Schering-Plough to be our partner. Our purpose is to support Schering-Plough’s business in Finland with the help of our advanced IT solution services”, says Mr Matti Lievonen, Director of Pharmaceutical Distribution.

Schering-Plough Oy is a Finnish subsidiary ( of the international science-based healthcare company Schering-Plough Corporation. Through international research Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs in the areas of cardiovascular and metabolic diseases, central nervous system disorders, infectious diseases, inflammatory diseases, oncology, and respiratory diseases The company is based in Kenilworth, N.J., USA.

Oriola-KD Corporation

Oriola-KD Corporation is a leading company in pharmaceutical distribution and trade as well as in healthcare and dental trade with business operations in Finland, Sweden, Denmark and Baltic Countries. Invoicing in 2005 was EUR 2.4 billion and the number of personnel is 1.500. Oriola-KD is listed on Helsinki Stock Exchange.


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.